Live Breaking News & Updates on David Schull Russo

Stay updated with breaking news from David schull russo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Patrick J. McEnany, Chairman and CEO of Catalyst Pharmaceuticals, Receives Prestigious 2023 Lifetime Achievement Award from BioFlorida

CORAL GABLES, Fla., Oct. 16, 2023 (GLOBE NEWSWIRE) Catalyst Pharmaceuticals, Inc. ("Catalyst" or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company, today announced that Patrick J. McEnany, Founder, Chairman and CEO of Catalyst, has been bestowed the 2023 Lifetime Achievement Award by BioFlorida at their Annual Meeting last Friday. This prestigious award highlights Mr. McEnany's outstanding accomplishments, unwavering commitment to rare disease patients, dedication to Cat ....

United States , Coral Gables , David Schull Russo , Nancyk Bryan , Patrickj Mcenany , Patrick Mcenany , Exchange Commission , Mary Coleman Catalyst Pharmaceuticals , Catalyst Pharmaceuticals , Humane Society Of Greater Miami , Catalyst Or Company Nasdaq , Watson Pharmaceuticals Inc , Jackson Health Foundation , National Association Of Pharmaceutical Manufacturers , Royce Laboratories Inc , Corporate Development For Watson , Catalyst Pharmaceuticals Inc , Health Canada , Achievement Award , Annual Meeting , Chief Executive Officer , Royce Laboratories , Watson Pharmaceuticals , Vice President , Corporate Development , Vice Chairman ,

Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference

Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Patrickj Mcenany , David Schull Russo , Health Canada , Catalyst Pharmaceuticals , Mary Coleman Catalyst Pharmaceuticals , Exchange Commission , Catalyst Pharmaceuticals Inc , Global Healthcare Conference , Global Healthcare Conferencedate , Catalyst Pharmaceuticalswith , North America , Duchenne Muscular , Fast Track , Full Prescribing , Safety Information , Full Prescribing Information , Looking Statementsthis , Annual Report , Relations Contact , David Schull Russo Partners ,

Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference - Catalyst Pharmaceuticals (NASDAQ:CPRX)

CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ:CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and ....

United States , David Schull Russo , Patrickj Mcenany , Exchange Commission , Mary Coleman Catalyst Pharmaceuticals , Catalyst Pharmaceuticals Inc , Catalyst Pharmaceuticals , Health Canada , Global Healthcare Conference , Global Healthcare , North America , Duchenne Muscular , Fast Track , Full Prescribing , Safety Information , Full Prescribing Information , Annual Report , Relations Contact , David Schull Russo Partners ,

Catalyst Pharmaceuticals Announces Abstract on Lambert Eaton Myasthenic Syndrome (LEMS) to be ...

CORAL GABLES, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for ....

United States , Patrickj Mcenany , David Morrell , David Schull Russo , Lambert Eaton , Catalyst Pharmaceuticals Inc , Health Canada , American Cancer Society , Global Health , Marketing At Catalyst Pharmaceuticals , Exchange Commission , Health Services , Investor Contact Mary Coleman Catalyst Pharmaceuticals Inc , Health Economics , Lung Cancer , International Association , Real World , Lambert Eaton Myasthenic Syndrome , Small Cell Lung Cancer , North America , Duchenne Muscular , Fast Track , Catalyst Pharmaceuticals , Full Prescribing , Safety Information , Full Prescribing Information ,

Catalyst Pharmaceuticals Reports Strong Second Quarter 2023 Financial Results and Provides Corporate Update

Catalyst Pharmaceuticals Reports Strong Second Quarter 2023 Financial Results and Provides Corporate Update
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United States , South Korea , Tamar Thompson , David Schull Russo , Dydo Pharma , Patrickj Mcenany , Exchange Commission , Devices Agency , Company Quarterly Report On Form , Health Canada , Development Expenses , Catalyst Pharmaceuticals Inc , Santhera Pharmaceuticals , Company Nasdaq , International Number , Catalyst Pharmaceuticals , Investor Contact Mary Coleman Catalyst Pharmaceuticals Inc , Net Revenues , Quarter Net Revenues , North American License , Maximum Indicated Dose , Full Year , Revenue Guidance , North American , Three Months Ended June , Income Per Share ,